New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then, The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and Analysis: The peptide problem: Hype is outrunning the evidence McMaster News Is BPC 157 Legal? Understanding Its Status and Implications of the Federal Food, Drug, and Cosmetic Act (FDCA).*